(Press-News.org) An upconversion organic light-emitting diode (OLED) based on a typical blue-fluorescence emitter achieves emission at an ultralow turn-on voltage of 1.47 V, as demonstrated by researchers from Tokyo Tech. Their technology circumvents the traditional high voltage requirement for blue OLEDs, leading to potential advancements in commercial smartphone and large screen displays.
Blue light is vital for light-emitting devices, lighting applications, as well as smartphone screens and large screen displays. However, it is challenging to develop efficient blue organic light-emitting diodes (OLEDs) owing to the high applied voltage required for their function. Conventional blue OLEDs typically require around 4 V for a luminance of 100 cd/m2; this is higher than the industrial target of 3.7 V—the voltage of lithium-ion batteries commonly used in smartphones. Therefore, there is an urgent need to develop novel blue OLEDs that can operate at lower voltages.
In this regard, Associate Professor Seiichiro Izawa from Tokyo Institute of Technology and Osaka University, collaborated with researchers from University of Toyama, Shizuoka University, and the Institute for Molecular Science has recently presented a novel OLED device with a remarkable ultralow turn-on voltage of 1.47 V for blue emission and a peak wavelength at 462 nm (2.68 eV) (as shown in Figure 1). Their work will be published in Nature Communications.
The choice of materials used in this OLED significantly influences its turn-on voltage. The device utilizes NDI-HF (2,7-di(9H-fluoren-2-yl)benzo[lmn][3,8]-phenanthroline-1,3,6,8(2H,7H)-tetraone) as the acceptor, 1,2-ADN (9-(naphthalen-1-yl)-10-(naphthalen-2-yl)anthracene) as the donor, and TbPe (2,5,8,11-tetra-tert-butylperylene) as the fluorescent dopant. This OLED operates via a mechanism called upconversion (UC). Herein, holes and electrons are injected into donor (emitter) and acceptor (electron transport) layers, respectively. They recombine at the donor/acceptor (D/A) interface to form a charge transfer (CT) state. Dr. Izawa points out: “The intermolecular interactions at the D/A interface play a significant role in CT state formation, with stronger interactions yielding superior results.”
Subsequently, the energy of the CT state is selectively transferred to the low-energy first triplet excited states of the emitter, which results in blue light emission through the formation of a high-energy first singlet excited state by triplet-triplet annihilation (TTA). “As the energy of the CT state is much lower than the emitter's bandgap energy, the UC mechanism with TTA significantly decreases the applied voltage required for exciting the emitter. As a result, this UC-OLED reaches a luminance of 100 cd/m2, equivalent to that of a commercial display, at just 1.97 V,” explains Dr. Izawa.
In effect, this study efficiently produces a novel OLED, with blue light emission at an ultralow turn-on voltage, using a typical fluorescent emitter widely utilized in commercial displays, thus marking a significant step toward meeting the commercial requirements for blue OLEDs. It emphasizes the importance of optimizing the design of the D/A interface for controlling excitonic processes and holds promise not only for OLEDs but also for organic photovoltaics and other organic electronic devices.
Let us hope that this technology gets commercialized soon!
###
About Tokyo Institute of Technology
Tokyo Tech stands at the forefront of research and higher education as the leading university for science and technology in Japan. Tokyo Tech researchers excel in fields ranging from materials science to biology, computer science, and physics. Founded in 1881, Tokyo Tech hosts over 10,000 undergraduate and graduate students per year, who develop into scientific leaders and some of the most sought-after engineers in industry. Embodying the Japanese philosophy of “monotsukuri,” meaning “technical ingenuity and innovation,” the Tokyo Tech community strives to contribute to society through high-impact research.
https://www.titech.ac.jp/english/
About Osaka University
Osaka University was founded in 1931 as one of the seven imperial universities of Japan and is now one of Japan's leading comprehensive universities with a broad disciplinary spectrum. This strength is coupled with a singular drive for innovation that extends throughout the scientific process, from fundamental research to the creation of applied technology with positive economic impacts. Its commitment to innovation has been recognized in Japan and around the world, being named Japan's most innovative university in 2015 (Reuters 2015 Top 100) and one of the most innovative institutions in the world in 2017 (Innovative Universities and the Nature Index Innovation 2017). Now, Osaka University is leveraging its role as a Designated National University Corporation selected by the Ministry of Education, Culture, Sports, Science and Technology to contribute to innovation for human welfare, sustainable development of society, and social transformation.
https://resou.osaka-u.ac.jp/en
END
Novel organic light-emitting diode with ultralow turn-on voltage for blue emission
2023-09-20
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Canadian older adults with COPD faced high levels of depression during the COVID pandemic
2023-09-20
A new longitudinal study published online in the International Journal of Chronic Obstructive Pulmonary Disease found that older adults with COPD had a heightened risk of depression during the early stages of the COVID-19 pandemic.
Researchers examined a sample of 875 individuals with COPD from the Canadian Longitudinal Study on Aging, a national study of Canadian older adults. Using longitudinal data, researchers were able to differentiate between 369 respondents with COPD who had a pre-pandemic history of depression and 506 respondents who had never experienced ...
Targeting Epstein-Barr virus to treat and prevent MS
2023-09-20
Recent evidence strongly implicates infection by the Epstein-Barr virus (EBV) as the trigger for development of multiple sclerosis (MS). An international research team is now gathering to unveil the role of EBV in the onset and progression of the MS disease.
The team has ambitious goals:
“We aim to find out why only a few EBV infected people develop MS, and define the underlying mechanism of this process”, explains the principal investigator (PI), Professor Kjell-Morten Myhr of the University of Bergen.
“Our research will also seek to investigate if targeting the EBV infection with antiviral treatments can improve the disease course or even stop ...
Can cognitive-behavioral therapy lessen fibromyalgia pain?
2023-09-20
In a recent randomized clinical trial of patients with fibromyalgia, cognitive-behavioral therapy (CBT)—which uses structured techniques to alter distorted thoughts and negative moods—was superior to a matched education treatment in reducing the interfering effects of pain and other aspects of fibromyalgia on daily living.
Within the group that received CBT in the trial, which is published in Arthritis & Rheumatology, improvements were at least partly attributable to reductions in what’s known as catastrophizing, a state comprised of cognitive and emotional processes such as helplessness, rumination, and magnification of ...
Can creatine supplements help people suffering from post-COVID-19 fatigue?
2023-09-20
The amino acid creatine is essential for muscle and brain health, and people commonly use creatine supplements to improve exercise performance and increase muscle mass. Results from a recent clinical trial published in Food Science & Nutrition indicate that dietary creatine may also benefit individuals experiencing post-COVID-19 fatigue syndrome (also known as long COVID).
In the trial, 12 people with post-COVID-19 fatigue syndrome were randomized to take a placebo or 4 grams of creatine monohydrate per day for ...
How will sea level rise affect the health of freshwater mussels and other salt-sensitive species?
2023-09-20
Investigators recently studied several species of freshwater mussels, which are endangered and are especially sensitive to changes in water quality, to explore the ramifications of sea-level rise in coastal rivers. The research published in Environmental Toxicology and Chemistry determined the concentration of sea salt that would harm the viability of young mussels.
The study focused on the ecosystems along the southeastern US coast, where sea-level measurements have indicated rising waters from 2 to 6mm per year. By detailing the levels in which salt water is toxic to mussels at various life stages, the results can provide guidance for conservation programs ...
Can artificial intelligence predict the risk of dying in the years following a hip fracture?
2023-09-20
A new study published in the Journal of Orthopaedic Research indicates that an artificial intelligence–based model trained on basic blood and lab test data as well as basic demographic data can predict a patient’s risk of death within 1-, 5-, and 10-years of experiencing a hip fracture.
In the analysis of 3,751 hip fracture patient records from two in‐hospital database systems at the Beth Israel Deaconess Medical Center in Boston, the 1‐year mortality rate for all patients was 21% and for those aged 80 years and older was 29%. After assessing 10 different machine learning classification ...
Study reveals the most important considerations for grizzly bear conservation
2023-09-20
Humans negatively impact the health of grizzly bear populations through top-down influences like direct mortality associated with forestry roads (from conflict or illegal killings) and displacement from high quality habitats, and through bottom-up influences like reducing availability of food resources. Research published in Wildlife Monographs reveals the relationship between these forces, informing a strategic conservation program.
Investigators radio-collared and followed numerous grizzly bears over multiple years in southeastern British Columbia. They found an interesting interplay between the most important bottom-up factor, ...
Cognitive behavioral therapy eases how fibromyalgia pain is experienced by the brain
2023-09-20
Patients living with fibromyalgia (FM) – a disease that predominantly affects women and is characterized by chronic pain, fatigue and brain fog – often find limited treatment options and a scarcity of explanations for their symptoms. Research led by Mass General Brigham investigators has found that cognitive behavioral therapy (CBT) can significantly reduce the burden of FM by, in part, reducing pain-catastrophizing, a negative cognitive and emotional response that can intensify pain through feelings of helplessness, rumination and intrusive thoughts. This finding is backed by neuroimaging ...
How bats evolved to avoid cancer
2023-09-20
A new paper in Genome Biology and Evolution, published by Oxford University Press, shows that rapid evolution in bats may account for the animals’ extraordinary ability to both host and survive infections as well as avoid cancer.
Bats are exceptional among mammals for not only their ability to fly but also their long lives, low cancer rates, and robust immune systems. Bats are also thought to have played a role in the emergence of SARS-CoV-2. The ability of bats to tolerate viral infections may stem from unusual features ...
High-quality single-cell transcriptomics from tissue sections reveals histology-associated heterogeneity of mouse follicles
2023-09-20
【Summary】
A research group led by Professor Kazuki Kurimoto and Assistant Professor Hiroki Ikeda from the Department of Embryology at Nara Medical University has developed a highly sensitive method for quantitative single-cell transcriptome analysis, which enables the precise examination of cells extracted from tissue sections using laser capture microdissection (LCM), and named the method DRaqL (Direct RNA recovery and quenching for LCM). Moreover, this method allows quantification of exon-exon junctions of mRNA. In an application of DRaqL to mouse ovarian sections, the research group established a predictive model for oocyte transcriptomes based on their diameter. Remarkably, ...